The pharmaceutical industry's ability to produce effective and safe medications hinges on the quality of its raw materials, particularly Active Pharmaceutical Ingredients (APIs) and their precursor intermediates. One such critical intermediate is 2-Butyl-3-(3,5-diiodo-4-hydroxybenzoyl)benzofuran (CAS 1951-26-4), an essential compound used in the synthesis of Amiodarone hydrochloride, a vital medication for treating cardiac arrhythmias.

The process of API manufacturing demands intermediates that meet rigorous purity standards. For 2-Butyl-3-(3,5-diiodo-4-hydroxybenzoyl)benzofuran, this includes a high assay of not less than 98.0% and not more than 102.0% on a dry basis, with strict limits on single and total impurities. Its physical appearance as an off-white crystalline powder is also a key quality indicator. These specifications are not arbitrary; they directly influence the quality, safety, and efficacy of the final drug product, which in this case, targets serious cardiac conditions like myocardial infarction and angina pectoris.

Sourcing these high-purity intermediates requires robust supplier relationships and stringent quality control measures. Pharmaceutical companies often partner with specialized chemical manufacturers that can guarantee consistent quality and reliable supply. For example, companies looking to buy 2-Butyl-3-(3,5-diiodo-4-hydroxybenzoyl)benzofuran need assurance that the product meets all regulatory and internal quality benchmarks. The role of suppliers like NINGBO INNO PHARMCHEM CO.,LTD. is therefore paramount, as they act as the gateway to these essential chemical building blocks.

The chemical properties of this intermediate, such as its molecular formula (C19H16I2O3) and molecular weight (546.14 g/mol), are well-documented, facilitating its use in synthesis. Furthermore, adherence to proper storage conditions, such as keeping it in a cool, dry, and well-ventilated place, is crucial for maintaining its chemical integrity until it is used in production. This attention to detail at every stage, from sourcing to storage, is what underpins the successful manufacture of critical pharmaceuticals.

In conclusion, the availability of high-purity pharmaceutical intermediates like 2-Butyl-3-(3,5-diiodo-4-hydroxybenzoyl)benzofuran is a cornerstone of modern pharmaceutical production. The collaborative effort between intermediate suppliers and API manufacturers ensures that vital medications can be produced consistently and safely, ultimately benefiting patient health worldwide.